New technologies and treatment methods are expanding men’s options. Here’s what you should know about your choices for ...
Scientists use a metric called “area under the curve” or AUC to assess how well the test performed. An AUC of 1 is a perfect ...
Prostate cancer is one of the most common cancers affecting men in the United States, and it comes with a heavy price tag. Nearly 300,000 men are expected to be diagnosed this year, and treatment ...
FDA-authorized AI tools have the potential to help patients with prostate cancer get clearer answers instead of waiting weeks for genomic test results. FDA-authorized artificial intelligence (AI) ...
The US FDA has granted De Novo marketing authorization for ArteraAI Prostate (Artera, Los Altos, California), a novel artificial intelligence (AI)-powered risk-stratification tool for patients with ...
SYRACUSE, N.Y.--(BUSINESS WIRE)--Associated Medical Professionals (A.M.P.) announced today the availability of the ArteraAI Prostate Test, an AI-powered risk stratification tool to help personalize ...
Results of Five Years of a Cancer Patient Navigation Training Program for Limited-Resource Settings in the Caribbean and Africa The study was performed in three stages at three Nigerian tertiary ...
BAY COUNTY, Fla. (WMBB) – Behind breast cancer, prostate cancer is the second most common cancer in the United States. Since its opening in 2012, the Hope Regional Cancer Center has been treating all ...
Behind breast cancer, prostate cancer is the second most common cancer in the United States. Since its opening in 2012, the Hope Regional Cancer Center has been treating all types of cancers. For more ...
Researchers at the Icahn School of Medicine at Mount Sinai have developed an advanced artificial intelligence (AI)-driven tool to improve the management and prognosis of prostate cancer. Recent ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback